NTRR Expands Business Model With New Potential Revenue Streams


NTRR Expands Business Model With New Potential Revenue Streams

SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, added a new potential revenue stream to its portfolio this week by signing a joint venture agreement with Second Wave Ventures, LLC, a cutting-edge developer of nutraceutical products.

Based in Los Angeles, Second Wave Ventures is on the cutting edge of technology innovations poised to change the way patients ease chronic pain and neurological symptoms. The company will partner with NTRR in marketing and developing new delivery systems capable of improving the way that the body absorbs nutrients and other active ingredients in medical marijuana and other natural remedies.

The new joint venture also plans to collaborate on a revolutionary new system designed to test MMJ oils for contaminants such as butane and pesticides.

"We're very excited about Second Wave's product innovations, which we believe will boost our company's revenue potential significantly," said NTRR CEO Sydney Jim.

NTRR is aggressively targeting potential partnerships with California companies on the cusp of delivering advanced new technologies and products to a growing marketplace of MMJ patients hungry for more predictable and manageable all-natural wellness solutions.

Thanks to joint ventures with emerging firms Second Wave Ventures, LLC, Vertigo Technologies, LLC, and Field of View Technologies, LLC, NTRR is on the cusp of delivering potentially lucrative new advancements in the processing and usage of cannabis in approved markets.

The company expects to announce new development details in the coming weeks.

By providing innovative products and services related to MMJ, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (CBIS), Medical Marijuana Inc. (MJNA) and Terra Tech Corp. (TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR's initiatives, please visit www.neutracorp.com.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO

KEYWORDS: United States North America Florida


The article NTRR Expands Business Model With New Potential Revenue Streams originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.